News Digest 2011
ECDC about Global Action Plan for Influenza Vaccines
30 June - European Centre for Disease Prevention and Control highlighted the recent supplement of the journal Vaccine on the GAP technology transfer project.
Swine flu vaccine safe in pregnancy: study
29 June - The swine flu shot appears to be safe for pregnant women, according to a new government report that tallies health problems occurring after the vaccinations.
Infectious disease experts call for better understanding of how to protect older Americans from influenza
29 June - Americans 65 years of age and older are at the highest risk of developing severe complications from influenza, but these same individuals receive less protection from annual influenza vaccination than others.
Flu Vaccine Safe for Sunitinib, Sorafenib Treated Patients
28 June - Patients undergoing chemotherapy with sunitinib or sorafenib develop seroprotection rates similar to healthy controls following vaccination against influenza, according to a study published online June 28 in Clinical Cancer Research.
Scientists edge closer to edible vaccine
28 June - Australian scientists are edging closer towards developing a revolutionary vaccine which can be swallowed in food instead of being injected. Clinical trials led by Nobel Prize winner Dr Barry Marshall have identified certain strains of a stomach bacteria which are safe to use in humans as the basis for edible vaccines.
Vaccines Protect the Youngest Babies
28 June - Two new studies offer good news for newborns and children about two different vaccinations — flu vaccine for pregnant women, and rotavirus vaccine for infants. There is no flu vaccine licensed for children under 6 months, and infants that age have the highest rates of pediatric influenza hospitalization. But a flu vaccine can still protect them if their mothers get the shot when they are pregnant. Most women now do just that — during the H1N1 flu epidemic of 2009-10, for example, 51 percent of pregnant women were vaccinated, compared with only 9 percent in 2002-3.
Federal review outlines new flu vaccine investments, challenges
28 June - Report released yesterday by the Government Accountability Office (GAO) offers yet another review of lessons from the federal government's response to the H1N1 influenza pandemic while detailing how the government spent, and is still spending, $6.15 billion that was appropriated for the response.
Considering vaccine as public responsibility
24 June - Lots of research shows that vaccination for the sake of others "is not a message that parents generally find motivating," said Kristine Sheedy, who oversees immunization media campaigns at the US Centers for Disease Control and Prevention.
Flu jab for all under fives could save 'thousands of people'
24 June - Thousands of lives could be saved a year if all young children were vaccinated annually against flu, say Oxford University academics.
ACIP Recommends Flu Vaccine for Egg-Allergic Persons
23 June - Influenza vaccine should be given to persons with less severe egg allergies, as long as certain conditions are observed, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted at its June 23 meeting.
New drug plants to boost Thailand's self-reliance
22 June - The new vaccine plant in Saraburi will employ Russian technology, which was transferred under an umbrella WHO project initiated in 2006 to boost global flu vaccine production capacity, particularly in countries lacking in such technology.
The ‘Decade Of Vaccines’: Promise And Challenge
14 June - The new Health Affairs volume explores the strategies that will be necessary to seize these opportunities, from investing in new science and building creative models of vaccine development and financing to improving the “supply chains” that distribute vaccines from manufacturers to the most remote clinics.
Influenza immunization: more support from donors
13 June - The Global Alliance on Vaccines and Immunization (GAVI) met with donor groups at a pledging conference in London on June 13. Major public and private donors committed vaccine funding to immunise more than 250 million of the world’s poorest children by 2015. Immunization against Haemophilus influenzae type b (Hib) is one of priorities for GAVI that provides support to routine immunisation programmes and encourages one-off tactical campaign investments